UCB reaches agreement with U.S. government on medicine costs
UCB says it has come to an agreement with the U.S. government to lower the cost of medicine and strengthen U.S. manufacturing.
Story updates
08:33:38 PM UTC
SquawkNews
Will Not Be Subject To Section 232 Pharmaceutical Tariffs Or Future Pricing Mandates - To Donate Keppra API And Tablets To ASPR National Stockpile
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.